Evidence map›Paper›PMID 29338750›Full record

ReviewBMC neurology2018

Reperfusion therapy in acute ischemic stroke: dawn of a new era?

Sonu Bhaskar, Peter Stanwell, Dennis Cordato, John Attia, Christopher Levi

Registry-linked trialAbstract readReview
In one paragraph

Review in BMC neurology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06721338 (Safety and Efficacy of Mechanical Thrombectomy Utilizing Reversal Flow), which is not on this map. Cited by 105 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
105citing papers in PubMed, 7 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06721338 phase1terminatednot on this mapstarted 2025, after this paper: background citation

Safety and Efficacy of Mechanical Thrombectomy Utilizing Reversal Flow

TypeinterventionalSponsorMediSys Health NetworkRan2025 to 2025Enrolled3ConditionsStroke, Large Vessel OcclusionArmsMechanical thrombectomy via blood flow reversal using BOBBY balloon guide catheter
3 · Its place in the literature

Who cites it

105 citing papers in PubMed, 7 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Effect and mechanisms of resveratrol in animal models of ischemic stroke: A systematic review and Bayesian meta-analysis.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2023
    Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Prehospital neuroprotectant in combination with post-arrival thrombolytic therapy for acute ischemic stroke. Secondary analysis of the FAST-MAG prehospital trial.Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association · 2026
    Trial
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. HCNS neuroscience & therapeutics · 2025
    Article
  18. Review
  19. Article
  20. Article

45 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sonu BhaskarWestern Sydney University (WSU), School of Medicine, South West Sydney Clinical School, Sydney, NSW, 2170, Australia. Sonu.Bhaskar@health.nsw.gov.au.ORCID http://orcid.org/0000-0002-9783-3628
Peter StanwellPriority Research Centre for Stroke & Brain Injury, Faculty of Health & Medicine, Hunter Medical Research institute (HMRI) and School of Medicine & Public Health, University of Newcastle, Newcastle, NSW, Australia.
Dennis CordatoLiverpool Hospital, Department of Neurology & Neurophysiology, Liverpool, 2170, NSW, Australia.
John AttiaPriority Research Centre for Stroke & Brain Injury, Faculty of Health & Medicine, Hunter Medical Research institute (HMRI) and School of Medicine & Public Health, University of Newcastle, Newcastle, NSW, Australia.
Christopher LeviWestern Sydney University (WSU), School of Medicine, South West Sydney Clinical School, Sydney, NSW, 2170, Australia. Christopher.Levi@unsw.edu.au.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Following the success of recent endovascular trials, endovascular therapy has emerged as an exciting addition to the arsenal of clinical management of patients with acute ischemic stroke (AIS). In this paper, we present an extensive overview of intravenous and endovascular reperfusion strategies, recent advances in AIS neurointervention, limitations of various treatment paradigms, and provide insights on imaging-guided reperfusion therapies. A roadmap for imaging guided reperfusion treatment workflow in AIS is also proposed. Both systemic thrombolysis and endovascular treatment have been incorporated into the standard of care in stroke therapy. Further research on advanced imaging-based approaches to select appropriate patients, may widen the time-window for patient selection and would contribute immensely to early thrombolytic strategies, better recanalization rates, and improved clinical outcomes.

Indexed as

Brain IschemiaEndovascular ProceduresFibrinolytic AgentsHumansPatient SelectionReperfusionStrokeThrombolytic TherapyTreatment OutcomeFibrinolytic AgentsEndovascular treatmentNeurointerventionPrognosisReperfusion therapyStroke

Identifiers

PMID29338750
PMCPMC5771207

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.